
New COO for Lonza Life Science Ingredients
pharmafile | June 8, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing | Beat In-Albon, COO, Lonza
Lonza has appointed Beat In-Albon as chief operating officer of its Life Science Ingredients sector.
In-Albon, 60, becomes a member of the management committee, replacing Harry Boot. In-Albon brings broad industry experience to his role, having worked for Lonza previously from 1983-2006 as head of the Organic Fine & Performance Chemicals Division, and for SGS from 2006-2012, where he held different management positions.
In-Albon will focus primarily on the project ‘Visp Challenge’, which is of significant importance to the expected profitability improvements in this sector.
Richard Ridinger, chief executive of Lonza said: “I’m really happy to have Beat In-Albon back with Lonza. He brings on the one hand in-depth knowledge of the LSI business and the Visp site, and on the other hand valuable outside views.”
Harry Boot will step down from the management committee and concentrate on his activities in Asia, especially in China.
Related Content

Lonza to acquire biologics site in Vacaville, US from Roche for $1.2bn
Lonza has announced that it has signed an agreement to acquire the Genentech large-scale biologics …

Lonza to acquire Synaffix to strengthen ADC development
Global manufacturer for the pharmaceutical, biotech and nutraceutical markets, Lonza has announced that it has …

Moderna submits BLA with FDA for COVID vaccine
Moderna has initiated the rolling submission process with the FDA for a Biologics License Application …






